TrialBreast cancer research and treatment2023

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.

Binghe Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.